NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of WageWorks, Inc. (NYSE:WAGE), Maxwell Technologies, Inc. (NASDAQ:MXWL), Valeritas Holdings, Inc. (NASDAQ:VLRX), NantKwest, Inc. (NASDAQ:NK), Nightstar Therapeutics PLC Sponsored ADR (NASDAQ:NITE), and Aspen Group Inc. (NASDAQ:ASPU), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WAGE DOWNLOAD: http://Capital-Review.com/register/?so=WAGE
MXWL DOWNLOAD: http://Capital-Review.com/register/?so=MXWL
VLRX DOWNLOAD: http://Capital-Review.com/register/?so=VLRX
NK DOWNLOAD: http://Capital-Review.com/register/?so=NK
NITE DOWNLOAD: http://Capital-Review.com/register/?so=NITE
ASPU DOWNLOAD: http://Capital-Review.com/register/?so=ASPU

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine WageWorks, Inc. (NYSE:WAGE), Maxwell Technologies, Inc. (NASDAQ:MXWL), Valeritas Holdings, Inc. (NASDAQ:VLRX), NantKwest, Inc. (NASDAQ:NK), Nightstar Therapeutics PLC Sponsored ADR (NASDAQ:NITE), and Aspen Group Inc. (NASDAQ:ASPU) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WAGEWORKS, INC. (WAGE) REPORT OVERVIEW

WageWorks' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, WageWorks reported revenue of $113.97MM vs $114.85MM (down 0.76%) and analysts estimated basic earnings per share $0.05 vs $0.23 (down 78.26%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, WageWorks reported revenue of $476.10MM vs $355.56MM (up 33.90%) and analysts estimated basic earnings per share $1.41 vs $0.44 (up 220.45%). Analysts expect earnings to be released on March 16th, 2020. The report will be for the fiscal period ending March 31st, 2019. The estimated EPS forecast for the next fiscal year is $1.20 and is expected to report on March 18th, 2019.

To read the full WageWorks, Inc. (WAGE) report, download it here: http://Capital-Review.com/register/?so=WAGE

-----------------------------------------

MAXWELL TECHNOLOGIES, INC. (MXWL) REPORT OVERVIEW

Maxwell Technologies' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Maxwell Technologies reported revenue of -$1.15MM vs -$11.90MM and analysts estimated basic earnings per share -$0.11 vs -$0.25. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Maxwell Technologies reported revenue of $90.46MM vs $87.71MM (up 3.14%) and analysts estimated basic earnings per share -$0.89 vs -$1.22. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.93 and is expected to report on April 4th, 2019.

To read the full Maxwell Technologies, Inc. (MXWL) report, download it here: http://Capital-Review.com/register/?so=MXWL

-----------------------------------------

VALERITAS HOLDINGS, INC. (VLRX) REPORT OVERVIEW

Valeritas' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Valeritas reported revenue of $6.89MM vs $5.78MM (up 19.25%) and analysts estimated basic earnings per share $1.12 vs $1.43 (down 21.68%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Valeritas reported revenue of $26.40MM vs $20.25MM (up 30.39%) and analysts estimated basic earnings per share -$1.71 vs -$8.94. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$1.72. The estimated EPS forecast for the next fiscal year is -$0.47 and is expected to report on March 3rd, 2020.

To read the full Valeritas Holdings, Inc. (VLRX) report, download it here: http://Capital-Review.com/register/?so=VLRX

-----------------------------------------

NANTKWEST, INC. (NK) REPORT OVERVIEW

NantKwest's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, NantKwest reported revenue of $0.01MM vs $0.01MM (down 41.67%) and basic earnings per share -$0.22 vs -$0.31. For the twelve months ended December 31st, 2018 vs December 31st, 2017, NantKwest reported revenue of $0.05MM vs $0.05MM (up 4.44%) and analysts estimated basic earnings per share -$1.22 vs -$1.20. Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.35. The estimated EPS forecast for the next fiscal year is -$1.05 and is expected to report on April 1st, 2019.

To read the full NantKwest, Inc. (NK) report, download it here: http://Capital-Review.com/register/?so=NK

-----------------------------------------

NIGHTSTAR THERAPEUTICS PLC SPONSORED ADR (NITE) REPORT OVERVIEW

Nightstar Therapeutics PLC Sponsored ADR's Recent Financial Performance

Analysts expect earnings to be released on June 5th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.52. The estimated EPS forecast for the next fiscal year is -$1.56 and is expected to report on April 2nd, 2019.

To read the full Nightstar Therapeutics PLC Sponsored ADR (NITE) report, download it here: http://Capital-Review.com/register/?so=NITE

-----------------------------------------

ASPEN GROUP INC. (ASPU) REPORT OVERVIEW

Aspen Group's Recent Financial Performance

For the three months ended January 31st, 2019 vs January 31st, 2018, Aspen Group reported revenue of $8.49MM vs $5.70MM (up 48.98%) and analysts estimated basic earnings per share -$0.13 vs -$0.15. For the twelve months ended April 30th, 2018 vs April 30th, 2017, Aspen Group reported revenue of $22.02MM vs $14.25MM (up 54.57%) and analysts estimated basic earnings per share -$0.50 vs -$0.10. Analysts expect earnings to be released on July 11th, 2019. The report will be for the fiscal period ending April 30th, 2019. The reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the next fiscal year is -$0.21 and is expected to report on July 11th, 2019.

To read the full Aspen Group Inc. (ASPU) report, download it here: http://Capital-Review.com/register/?so=ASPU

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Morena Zambada, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.